Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Neoplasm

Explore clinical trials studying Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

115 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm trial results

Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

NCT03970096

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +19 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Recruiting

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT06059391

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +34 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • DFCI/BWH Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

NCT07119970

Conditions
Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations
  • CHU d'Angers, Service des maladies du Sang Angers, France
  • CH de la Côte Basque, Service Hématologie Bayonne, France
  • CHU de Bordeaux, Service Hématologie Biologique Bordeaux, France
  • CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire Bordeaux, France
View all 15 locations
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)

NCT05839717

Conditions
Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations
  • CHU d'Angers, Service Maladies du Sang Angers, France
  • CH de Bayonne, Service Hématologie Clinique Bayonne, France
  • CHU de Bordeaux, Service Médecine Interne et Maladies Infectieuses Bordeaux, France
  • Institut Bergonié, Service Hématologie Clinique Bordeaux, France
View Trial Details

Related conditions